Stuart Garay is a Respiratory physician. OpenAlex indexes 42 publications with 3,455 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
436 3rd Ave
New York, NY 100166025
Telephone
212-685-6660Provider last certified this registry record 10 Jun 2021.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
93.7%beta2-Adrenergic Agonist51.3%Albuterol84%Albuterol Sulfate Hfa8%Levalbuterol4%Ventolin Hfa3%Serevent Diskus1%Part D + Part B<11 patientsCorticosteroid27.1%Breo Ellipta37%Arnuity Ellipta24%Trelegy Ellipta14%Symbicort12%Budesonide-Formoterol Fumarate7%Fluticasone Propionate3%Fluticasone-Vilanterol3%Qvar Redihaler2%Part D<11 patients+ 4 more classes in this area
Anti-infectives
2.7%Macrolide Antimicrobial1.1%Azithromycin100%Part D≥20 patientsProtease inhibitors0.9%Paxlovid100%Part D≥22 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.3%Corticosteroid1%Prednisone100%Part D≥12 patientsH2 blocker0.6%Famotidine100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 209 Ketamine as a Rescue Drug for Patients Presenting With Benzodiazepine-Resistant Status Epilepticus
Annals of Emergency Medicine
2024 - Pulmonary Cryoablation Outcomes in Octogenarians and Nonagenarians with Primary Lung Cancer
Journal of Vascular and Interventional Radiology
2023 - Computed Tomography Evaluation of In Vivo Pulmonary Cryoablation Zone Sizes
Journal of Vascular and Interventional Radiology
2022 - 4:21 PM Abstract No. 155 Percutaneous image–guided lung cryoablation: technical and procedural factors impacting outcomes
Journal of Vascular and Interventional Radiology
2020 - Pulmonary Complications of the Acquired Immunodeficiency Syndrome: An Update
American Review of Respiratory Disease
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”